BC Platforms Partners with OmicsBank to Broaden Access to Large-Scale Health Data from India & UAE

The initiative aims to support a wide range of research activities, including drug discovery, clinical development, real-world evidence generation, and the development of advanced multimodal AI models in healthcare.

BC Platforms, a global provider of healthcare data technologies and analytics, has partnered with OmicsBank, a healthcare AI-ready data infrastructure company.

The collaboration seeks to expand access to extensive real-world clinical and multi-omics datasets from India and the United Arab Emirates (UAE).

As per the agreement, BC Platforms will integrate data from OmicsBank’s infrastructure into its global data network, which is expected to increase its patient coverage by adding more than 12 million lives from India and approximately 500,000 from the UAE.

The expanded network will provide access to over 187 million patient lives across more than 35 countries. The company further plans extend data coverage throughout India and other emerging markets, including Saudi Arabia, Taiwan, the Philippines, and Malaysia.

The datasets supplied by Omics Bank comprise millions of electronic medical records (EMRs) and large collections of pathology slides and medical imaging, extensive sequencing data, and connected biospecimens.

These resources can be accessed as modular datasets for focused research or as comprehensive longitudinal cohorts to support advanced analytics and artificial intelligence models developed in healthcare.

Once integrated into BC platforms' agentic AI data mastering platform, BC Unify, these datasets can be harmonized and provisioned via BC Mosaic, a federated trusted research structure, and BC Catalyst, designed to support users with insights generation and predictive analytics.

The features are intended to enable a broad range of research activities of early discovery and feasibility to clinical development, real-world performance insights, post-market evidence generation, and large-scale AI model training on complex, multi-modal healthcare data.

Commenting on the partnership, Mukhtar Ahmed, CEO, BC Platforms, said, "India's population scale, disease diversity, and growing role in clinical research make it invaluable from a scientific and regulatory perspective – and critical for life science companies that are seeking innovative targeted therapies and pursuing precision medicine strategies. Through our partnership with OmicsBank, we are expanding access to research-ready data from India and other emerging regions, thereby helping our customers to better understand, develop, and launch novel therapies supporting the unique needs of discrete patient populations around the world."

Stay tuned for more such updates on Digital Health News